huahaipharm(600521.SH)

Last Updated 00:00:00
longbridge loading

Chinese Drugmaker Huahai Rises After Signing USD340 Million Deal With Spain’s Almirall

Yicai·
SH
600521
+1.36%
Yicai·
SH
600521
+1.36%

The CSI Convertible Bond Index opened down 0.38%. Jiaze Convertible Bonds, Jingda Convertible Bonds, Bester Convertible Bonds, TZTEK Convertible Bonds, and HUAYA INTELLIGENCE Convertible Bonds saw the largest declines, falling 3.04%, 2.99%, 2.97%, 2.74%, and 2.69% respectively. ChangGao NEET Convertible Bonds, Shandong Head Group Convertible Bonds, TRE Convertible Bonds, JINHONG GAS Convertible Bonds, and huahaipharm Convertible Bonds led the gains, rising 30.00%, 10.00%, 3.87%, 3.83%, and 3.56% respectively

Wallstreetcn·
SH
600521
+1.36%
SH
688106
+0.96%
SH
中证转债
0.00%
Wallstreetcn·
SH
600521
+1.36%
SH
688106
+0.96%
SH
中证转债
0.00%

National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance

36Kr·
SZ
002038
+0.48%
SH
512290
+0.21%
SZ
000963
+0.07%
36Kr·
SZ
002038
+0.48%
SH
512290
+0.21%
SZ
000963
+0.07%

Huahaipharm's subsidiary, Ruixiqi's Bevacizumab Injection marketing authorization application has been accepted

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%

Huahaipharm: Carboxymethyl Sodium Injection has obtained a drug registration certificate

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%

Huahaipharm: Huaotai has received FDA approval to conduct Phase I clinical trials of injectable HB0043 in the United States

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%

Huahaipharm: Two products have obtained drug registration certificates

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%

Innovative drug concept stocks show partial strength, Thalys hits the limit up

Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
300436
+3.11%
Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
300436
+3.11%

Huahaipharm's subsidiary Huahai Jiancheng passes on-site inspection by the US FDA

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%

The chemical pharmaceutical sector fluctuated and weakened, with Huahai Pharmaceutical hitting the limit down

Zhitong·
SH
600521
+1.36%
Zhitong·
SH
600521
+1.36%
© 2026 Longbridge｜Disclaimer